T. Nigo

Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors.

H. Toda, N. Nomura, T. Sumiyoshi, 2014, Bioorganic & medicinal chemistry letters.

Syntheses of [14C]-labeled 2-(3-chlorophenyloxy)-3-[3-(3-hydroxy) pyridin-4-yl propoxy]pyridine, a phosphodiesterase 4 inhibitor and its metabolites.

Yusuke Sawayama, T. Sumiyoshi, M. Kawasaki, 2014, Journal of labelled compounds & radiopharmaceuticals.

Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors.

T. Sumiyoshi, Y. Teranishi, Akira Fusano, 2013, Bioorganic & medicinal chemistry.

Mechanistic study of base-promoted rearrangement of 1,5-dibromopentacyclo[5.3.0.02,5.03,9.04,8]decane-6,10-dione to 10-oxa-9-oxopentacyclo[5.3.0.02,4.03,6.05,8]decane-3-carboxylic acid

I. Ueda, Y. Kuwatani, T. Hasegawa, 1993 .

Base-promoted rearrangement of 1,5-dibromopentacyclo[5.3.0.02,5.03,9.04,8]-decane-6,10-dione : easy entry of a novel cage system, 10-oxa-9-oxopentacyclo[5.3.0.02,4.03,6.05,8]decane

I. Ueda, Y. Kuwatani, T. Hasegawa, 1993 .

Antiulcer agents. III. Synthesis and antiulcer activity of N-[3-(3-piperidinomethylphenoxy)propyl]pentacyclo[4.2.0.0(2,5).0(3,8).0 (4,7)]-octane carboxamides and related compounds.

H. Toyoda, T. Kakita, T. Hasegawa, 1993, Chemical & pharmaceutical bulletin.